CN104800700A - Chinese herbal medicine composition for treating skin diseases - Google Patents
Chinese herbal medicine composition for treating skin diseases Download PDFInfo
- Publication number
- CN104800700A CN104800700A CN201510264720.3A CN201510264720A CN104800700A CN 104800700 A CN104800700 A CN 104800700A CN 201510264720 A CN201510264720 A CN 201510264720A CN 104800700 A CN104800700 A CN 104800700A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- treatment
- herbal composite
- dermopathic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000017520 skin disease Diseases 0.000 title abstract description 20
- 241000411851 herbal medicine Species 0.000 title abstract description 7
- 239000000203 mixture Substances 0.000 title abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 19
- 239000002131 composite material Substances 0.000 claims description 40
- 241000628997 Flos Species 0.000 claims description 21
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims description 15
- 241000255791 Bombyx Species 0.000 claims description 13
- 201000004624 Dermatitis Diseases 0.000 abstract description 19
- 239000003814 drug Substances 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 16
- 208000010668 atopic eczema Diseases 0.000 abstract description 15
- 208000024780 Urticaria Diseases 0.000 abstract description 11
- 206010015150 Erythema Diseases 0.000 abstract description 9
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 abstract description 9
- 208000031814 IgA Vasculitis Diseases 0.000 abstract description 9
- 231100000321 erythema Toxicity 0.000 abstract description 9
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 abstract description 9
- 201000004681 Psoriasis Diseases 0.000 abstract description 8
- 241000218691 Cupressaceae Species 0.000 abstract 2
- 240000005528 Arctium lappa Species 0.000 abstract 1
- 235000003130 Arctium lappa Nutrition 0.000 abstract 1
- 235000008078 Arctium minus Nutrition 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 241001071917 Lithospermum Species 0.000 abstract 1
- 241000101040 Pityriasis Species 0.000 abstract 1
- 240000004980 Rheum officinale Species 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 244000007853 Sarothamnus scoparius Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 206010048768 Dermatosis Diseases 0.000 description 15
- 231100000614 poison Toxicity 0.000 description 12
- 208000003251 Pruritus Diseases 0.000 description 9
- 230000001225 therapeutic effect Effects 0.000 description 9
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 206010042674 Swelling Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010002198 Anaphylactic reaction Diseases 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 230000036783 anaphylactic response Effects 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 201000005404 rubella Diseases 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 229940126673 western medicines Drugs 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010021531 Impetigo Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 208000003014 Bites and Stings Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a Chinese herbal medicine composition for treating skin diseases. The Chinese herbal medicine composition comprises the following raw materials in parts by weight; 5 to 8 parts of rheum officinale, 5 to 8 parts of scutellaria baicalensis, 7 to 12 parts of golden cypress, 10 to 15 parts of cortex dictamni, 7 to 12 parts of rhizoma smilacis glabrae, 3 to 5 parts of stiff silkworm, 5 to 8 parts of lithospermum, 8 to 12 parts of burdock, 3 to 5 parts of wild chrysanthemum flowers, 8 to 15 parts of broom cypress fruit and 5 to 7 parts of divaricate saposhnikovia root. The Chinese herbal medicine composition has a curative effect on various skin diseases such as eczema, urticaria, psoriasis, pityriasis, erythema and anaphylactoid purpura, so that the skin diseases can be more thoroughly and more comprehensively treated, the treatment comprehensiveness of the traditional Chinese medicine can be effectively improved, and the problems in the prior art that the limitation of the Chinese and western medicine is large and the curative effect is poor can be solved.
Description
Technical field
The present invention relates to field of Chinese herbal, particularly relate to one and treat dermopathic herbal composite.
Background technology
Dermatosis is a kind of commonly encountered diseases, of a great variety, and the cause of disease is complicated, and the state of an illness is obstinate difficult.China's traditional Chinese medical science is roughly divided into two kinds dermatosis, skin infection and dermatosis.Skin infection common are: furuncle, furuncle, skin ulcer, carbuncle, erysipelas; The common of dermatosis has eczema, dermatitis, impetigo, urticaria, skin pruritus etc.Dermopathic main cause is caused to have: one is damp and hot too heavy, damp and hot poison contamination skin; Two is that certain allergies causes; Three is caused by fungal infection; Four are the unclean or worms of skin, mosquito, miliaria sting rear scratching brokenly with hands because itching and be infected by bacterial; Five is four seasons climate changes, wind, heat, cold, wetly causes morbidity; Six is that contact infection causes.Among the people dermatosis pathogenic factors is summarized as the category such as heat, wet, wind, summer-heat, the stagnation of QI, blood stasis, expectorant, poison, You Yire, wet, wind, poison attach most importance to.Traditional Chinese Medicine thinks that dermatosis pathogenesis is that the burning hot poison of diseases caused by exogenous pathogenic factor is evil, and interior sense asthenic fire is excessively prosperous.Many medical informations show, to be that Shi Re Bing Pian is overweight cause dermopathic core.
At present, treat above-mentioned dermatosis and be mainly divided into western medical treatment and Chinese traditional treatment, western medical treatment.Doctor trained in Western medicine is mainly with calm, stable, hypnosis and antihistamine, hormone medicine, or adopt procaine intravenous to close or calcium preparation intravenous injection, Western medicine is poor effect not only, and side effect is large, normal with untoward reaction such as skin allergy, easily cause when injected organism tissue and skin injury, and easily recur, the many hardships of patient its tire out.The traditional Chinese medical science is then mainly with dispelling wind dampness removing, heat clearing away, dampness removing, antipruritic; Or purging liver-fire, nourishing blood to expel wind is moisturized, and for the purpose of blood enriching and dryness moistening, often card one side, though with strong points, the scope of application is little, has larger limitation, and easily recurs.Meanwhile, minority Chinese herbal medicine formula has toxicity, and infringement patient body is healthy.
Summary of the invention
The invention provides one and treat dermopathic herbal composite, to solve, western medicines in treatment limitation of the prior art is large, therapeutic effect is not good.
The invention provides one and treat dermopathic herbal composite, the dermopathic herbal composite of described treatment comprises the raw material of following parts by weight: Radix Et Rhizoma Rhei 5-8 part, Radix Scutellariae 5-8 part, Cortex Phellodendri 7-12 part, Cortex Dictamni 10-15 part, Rhizoma Smilacis Glabrae 7-12 part, Bombyx Batryticatus 3-5 part, Radix Arnebiae (Radix Lithospermi) 5-8 part, Fructus Arctii 8-12 part, Flos Chrysanthemi Indici 3-5 part, Fructus Kochiae 8-15 part, Radix Saposhnikoviae 5-7 part.
Preferably, the dermopathic herbal composite of above-mentioned treatment also comprises the raw material of following parts by weight: Flos Lonicerae 5-8 part, Herba Lobeliae Chinensis 4-7 part, Mel 3-5 part.
Preferably, the dermopathic herbal composite of above-mentioned treatment comprises the raw material of following parts by weight: Radix Et Rhizoma Rhei 5 parts, Radix Scutellariae 7 parts, Cortex Phellodendri 8 parts, Cortex Dictamni 15 parts, Rhizoma Smilacis Glabrae 10 parts, Bombyx Batryticatus 3 parts, Radix Arnebiae (Radix Lithospermi) 8 parts, Fructus Arctii 11 parts, Flos Chrysanthemi Indici 4 parts, the Fructus Kochiae 12 parts, Radix Saposhnikoviae 6 parts.
Preferably, the dermopathic herbal composite of above-mentioned treatment also comprises the raw material of following parts by weight: Flos Lonicerae 8 parts, Herba Lobeliae Chinensis 5 parts, Mel 5 parts.
The technical scheme that embodiments of the invention provide can comprise following beneficial effect:
Radix Et Rhizoma Rhei: the effect such as removing heat from blood, blood stasis dispelling, removing toxic substances.
Radix Scutellariae: eliminating fire and detoxication, hemostasis, antibacterial.
Cortex Phellodendri: heat clearing and damp drying, pathogenic fire purging remove steaming, detoxification sore treatment, for damp-heat dysentery, jaundice, leukorrhagia, hectic fever due to YIN-deficiency consumptive fever, night sweat, sore swollen toxin, eczema pruritus.
Cortex Dictamni: heat-clearing and toxic substances removing, dispeiling pathogenic wind and removing dampness, killing parasites for relieving itching.
Rhizoma Smilacis Glabrae: removing toxic substances, damp eliminating heat, sharp joint, sore, carbuncle and painful swelling, eczema, impetigo, erysipelas, tinea pedis, dermatitis rhus etc. smelly for syphilis, damp and hot arthralgia, stranguria, leukorrhagia Huang.
Bombyx Batryticatus: there is expelling wind to relieve convulsion, effect of dissipating phlegm and resolving masses, is used for controlling tangible enclosed mass, as tuberosity, pharyngeal swelling pain, scrofula, wind skin ulcer urticaria etc.
Radix Arnebiae (Radix Lithospermi): removing heat from blood, invigorates blood circulation, heat clearing away, removing toxic substances.Cure mainly heat in blood poison to contain, macule purple is black, measles without adequate eruption, skin infection, eczema, carbuncle and ulcer.
Fructus Arctii: dispelling wind and heat pathogens, heat-clearing and toxic substances removing rash, lung qi dispersing sore-throat relieving is loose swollen.Cure mainly anemopyretic cold, epidemic febrile disease from the beginning of; Wind heat or cough due to lung-heat, cough up phlegm not smooth; Laryngopharynx swelling and pain; Macule is not saturating; At the measles initial stage, rash goes out not smooth and rubella pruritus; Sore swollen toxin and mumps etc.For the not yet routed person of hot carbuncle toxin, normal and Herba Violae, the heat and toxic materials clearing away medicine compatibilities such as Flos Chrysanthemi Indici
Flos Chrysanthemi Indici: heat-clearing and toxic substances removing, cures mainly cold, fever, carbuncle sore tumefacting virus, innominate toxic swelling, eczema, dermatitis, snake bite and insect sting etc.
The Fructus Kochiae: clearing away heat-damp and promoting diuresis, dispelling wind for relieving itching, cures mainly difficulty and pain in micturition, pudendal pruritus leukorrhagia, rubella, eczema, skin pruritus.
Radix Saposhnikoviae: expelling pathogenic wind from the body surface, removing dampness to relieve pain, relieving convulsion, cures mainly diseases caused by exogenous pathogenic factor exterior syndrome, rubella pruritus, rheumatic arthralgia, tetanus just, insufficiency of the spleen leading to overabundance of dampness.
The dermopathic herbal composite for the treatment of provided by the invention mainly comprises the raw materials such as Radix Et Rhizoma Rhei, Radix Scutellariae, Cortex Phellodendri, Cortex Dictamni, Rhizoma Smilacis Glabrae, Bombyx Batryticatus, Radix Arnebiae (Radix Lithospermi), Fructus Arctii, Flos Chrysanthemi Indici, the Fructus Kochiae and Radix Saposhnikoviae, all raw materials are pure natural Chinese herbal medicine, do not become containing any chemistry, to human skin action temperature and, the untoward reaction such as have no side effect and irritated, and therapeutic effect is good, instant effect.From effect of above-mentioned raw materials, the raw materials such as Radix Et Rhizoma Rhei, Radix Scutellariae, Cortex Phellodendri, Cortex Dictamni, Rhizoma Smilacis Glabrae, Bombyx Batryticatus, Radix Arnebiae (Radix Lithospermi), Fructus Arctii, Flos Chrysanthemi Indici, the Fructus Kochiae and Radix Saposhnikoviae have heat-clearing and toxic substances removing, effects such as treating skin ulcer of dispeling the wind.Wherein, Cortex Phellodendri, Cortex Dictamni are to the successful for the treatment of eczema; The Radix Angelicae Dahuricae, Cortex Dictamni, Rhizoma Smilacis Glabrae, Fructus Arctii are to the successful for the treatment of urticaria; Rhizoma Smilacis Glabrae, Radix Et Rhizoma Rhei, the Fructus Kochiae are to the psoriasic successful for the treatment of; The successful that Radix Arnebiae (Radix Lithospermi), Cortex Dictamni are examined treatment sugar; Radix Scutellariae, Cortex Phellodendri are to the successful for the treatment of erythema; Fructus Arctii, Radix Saposhnikoviae are to the successful for the treatment of anaphylactoid purpura.Therefore, the dermopathic herbal composite for the treatment of provided by the invention is not treat for a certain dermatosis, but to eczema, urticaria, psoriasis, sugar is examined, the multiple dermatosis such as erythema and anaphylactoid purpura is all good has therapeutic effect, make treating for skin disease more thoroughly, more comprehensively, effectively improve the comprehensive for the treatment of by Chinese herbs.It can thus be appreciated that, the invention provides one and treat dermopathic herbal composite, can solve that western medicines in treatment limitation of the prior art is large, therapeutic effect is not good.
Should be understood that, it is only exemplary and explanatory that above general description and details hereinafter describe, and can not limit the present invention.
Detailed description of the invention
Each embodiment in this description all adopts the mode of going forward one by one to describe, between each embodiment identical similar part mutually see, what each embodiment stressed is the difference with other embodiment.
Embodiment 1
One treats dermopathic herbal composite, and the dermopathic herbal composite of described treatment comprises the raw material of following parts by weight: Radix Et Rhizoma Rhei 5 parts, Radix Scutellariae 5 parts, Cortex Phellodendri 7 parts, Cortex Dictamni 10 parts, Rhizoma Smilacis Glabrae 7 parts, Bombyx Batryticatus 3 parts, Radix Arnebiae (Radix Lithospermi) 5 parts, Fructus Arctii 8 parts, Flos Chrysanthemi Indici 3 parts, the Fructus Kochiae 8 parts, Radix Saposhnikoviae 5 parts, Flos Lonicerae 5 parts, Herba Lobeliae Chinensis 4 parts, Mel 3 parts.
Embodiment 2
One treats dermopathic herbal composite, and the dermopathic herbal composite of described treatment comprises the raw material of following parts by weight: Radix Et Rhizoma Rhei 5 parts, Radix Scutellariae 7 parts, Cortex Phellodendri 8 parts, Cortex Dictamni 15 parts, Rhizoma Smilacis Glabrae 10 parts, Bombyx Batryticatus 3 parts, Radix Arnebiae (Radix Lithospermi) 8 parts, Fructus Arctii 11 parts, Flos Chrysanthemi Indici 4 parts, the Fructus Kochiae 12 parts, Radix Saposhnikoviae 6 parts.
Embodiment 3
One treats dermopathic herbal composite, and the dermopathic herbal composite of described treatment comprises the raw material of following parts by weight: Radix Et Rhizoma Rhei 5 parts, Radix Scutellariae 7 parts, Cortex Phellodendri 8 parts, Cortex Dictamni 15 parts, Rhizoma Smilacis Glabrae 10 parts, Bombyx Batryticatus 3 parts, Radix Arnebiae (Radix Lithospermi) 8 parts, Fructus Arctii 11 parts, Flos Chrysanthemi Indici 4 parts, the Fructus Kochiae 12 parts, Radix Saposhnikoviae 6 parts, Flos Lonicerae 8 parts, Herba Lobeliae Chinensis 5 parts, Mel 5 parts.
Embodiment 4
One treats dermopathic herbal composite, and the dermopathic herbal composite of described treatment comprises the raw material of following parts by weight: Radix Et Rhizoma Rhei 7 parts, Radix Scutellariae 7 parts, Cortex Phellodendri 11 parts, Cortex Dictamni 14 parts, Rhizoma Smilacis Glabrae 7 parts, Bombyx Batryticatus 3 parts, Radix Arnebiae (Radix Lithospermi) 7 parts, Fructus Arctii 10 parts, Flos Chrysanthemi Indici 4 parts, the Fructus Kochiae 13 parts, Radix Saposhnikoviae 5 parts, Flos Lonicerae 8 parts, Herba Lobeliae Chinensis 7 parts, Mel 5 parts.
Embodiment 5
One treats dermopathic herbal composite, and the dermopathic herbal composite of described treatment comprises the raw material of following parts by weight: Radix Et Rhizoma Rhei 7 parts, Radix Scutellariae 6 parts, Cortex Phellodendri 10 parts, Cortex Dictamni 11 parts, Rhizoma Smilacis Glabrae 10 parts, Bombyx Batryticatus 4 parts, Radix Arnebiae (Radix Lithospermi) 7 parts, Fructus Arctii 9 parts, Flos Chrysanthemi Indici 4 parts, the Fructus Kochiae 10 parts, Radix Saposhnikoviae 6 parts.
Embodiment 6
One treats dermopathic herbal composite, and the dermopathic herbal composite of described treatment comprises the raw material of following parts by weight: Radix Et Rhizoma Rhei 8 parts, Radix Scutellariae 8 parts, Cortex Phellodendri 12 parts, Cortex Dictamni 15 parts, Rhizoma Smilacis Glabrae 12 parts, Bombyx Batryticatus 5 parts, Radix Arnebiae (Radix Lithospermi) 8 parts, Fructus Arctii 12 parts, Flos Chrysanthemi Indici 5 parts, the Fructus Kochiae 15 parts, Radix Saposhnikoviae 7 parts.
Clinical trial
Experimental group:
Experimental subject: patient populations is 300, wherein eczema, urticaria, psoriasis, sugar are examined, erythema and patients with anaphylactoid purpura number be respectively 50.
Experimental technique: for the dermopathic herbal composite for the treatment of described in embodiment 2, be used for the treatment of dermatosis, uses two courses for the treatment of.
Matched group 1:
Experimental subject: patient populations is 300, wherein eczema, urticaria, psoriasis, sugar are examined, erythema and patients with anaphylactoid purpura number be respectively 50.
Experimental technique: select the medicine containing chemical composition that market is sold, be used for the treatment of dermatosis, use two courses for the treatment of.
Matched group 2:
Experimental subject: patient populations is 300, wherein eczema, urticaria, psoriasis, sugar are examined, erythema and patients with anaphylactoid purpura number be respectively 50.
Experimental technique: select the medicine containing Chinese herbal medicine that market is sold, be used for the treatment of dermatosis, use two courses for the treatment of.
It should be noted that, experimental group, matched group 1 are identical with M-F in the patient that matched group 2 is selected, and disease condition is identical, and skin skin quality is similar.
Efficacy assessment standard:
Recovery from illness: symptom disappears completely, face is as usual, no longer continues medication.
Effective: symptom has clear improvement, need continual cure.
Invalid: symptom, without improvement, need be treated with other drug.
Experimental result is as shown in table 1.
Table 1: the experimental data of clinical trial
| Recovery from illness number | Efficiently individual quantity | Invalid number | Effective quantity | Anaphylaxis | Recurrence | |
| Experimental group | 155 | 115 | 30 | 6 | Nothing | Nothing |
| Matched group 1 | 40 | 102 | 158 | 3 | Have | Have |
| Matched group 2 | 67 | 21 | 212 | 2 | Nothing | Have |
Effective quantity in table 1 is experimental group, matched group 1 and matched group 2 are examined for eczema, urticaria, psoriasis, sugar, the effective quantity of erythema and anaphylactoid purpura 6 kinds of diseases.As shown in Table 1, the dermopathic herbal composite of the treatment that the embodiment of the present invention 2 provides, eczema, urticaria, psoriasis, sugar are examined, erythema and patients with anaphylactoid purpura all have certain curative effect, and onset time is short, instant effect, after the treatment of two courses for the treatment of, 155 patient's recoveries from illness in 300 dermatosis patients, without the need to successive treatment, 115 patients obtain effective treatment, symptom be improved significantly, only have minority serious patient inefficacy.Use this herbal composite without untoward reaction such as allergy, and not easily recur.And the medicine containing chemical composition that matched group 1 provides, only to 3 kinds of dermatosiss, there is certain curative effect, and therapeutic effect is not good, only there is 40 people's recoveries from illness, has 158 patients and obviously do not take effect, need treat with other drug, the scope of application of medicine is less, and anaphylaxis appears in the patient of the facial film using matched group 1 to provide, and causes the injury to patient skin, meanwhile, there is the situation of recurrence in the patient of rehabilitation.The medicine containing medicinal herb components that matched group 2 provides, the scope of application is very little, is only suitable for two kinds of dermatosiss, and therapeutic effect is general, easily recurs.It can thus be appreciated that, herbal composite provided by the invention without allergy etc. without good reaction, therapeutic effect is good, not easily recur, eczema, urticaria, psoriasis, sugar are examined, erythema and patients with anaphylactoid purpura all have certain curative effect, applied widely, can solve that western medicines in treatment limitation of the prior art is large, therapeutic effect is not good.
For the clinical trial results of the dermopathic herbal composite for the treatment of provided in embodiment 1, embodiment 3, embodiment 4, embodiment 5 and embodiment 6 and the experimental result of embodiment 2 similar, all there is good therapeutic effect, applied widely, without bad anaphylaxis, and not easily recur.The clinical experiment effect of the dermopathic herbal composite of the treatment that embodiment 2 provides slightly is better than the clinical experiment effect of the dermopathic herbal composite for the treatment of provided in embodiment 1, embodiment 3, embodiment 4, embodiment 5 and embodiment 6, no longer illustrates here.
It should be noted that; the dermopathic herbal composite for the treatment of provided by the invention can make medicament, decoction, facial film and for various forms of preparations that are oral and external application; as long as treat the material composition in dermopathic herbal composite containing this, all in the scope of protection of the invention.
Above-described embodiment of the present invention, does not form limiting the scope of the present invention.Any amendment done within the spirit and principles in the present invention, equivalent replacement and improvement etc., all should be included within protection scope of the present invention.
Claims (4)
1. the dermopathic herbal composite for the treatment of, it is characterized in that, the dermopathic herbal composite of described treatment comprises the raw material of following parts by weight: Radix Et Rhizoma Rhei 5-8 part, Radix Scutellariae 5-8 part, Cortex Phellodendri 7-12 part, Cortex Dictamni 10-15 part, Rhizoma Smilacis Glabrae 7-12 part, Bombyx Batryticatus 3-5 part, Radix Arnebiae (Radix Lithospermi) 5-8 part, Fructus Arctii 8-12 part, Flos Chrysanthemi Indici 3-5 part, Fructus Kochiae 8-15 part, Radix Saposhnikoviae 5-7 part.
2. the dermopathic herbal composite for the treatment of according to claim 1, is characterized in that, the dermopathic herbal composite of described treatment also comprises the raw material of following parts by weight: Flos Lonicerae 5-8 part, Herba Lobeliae Chinensis 4-7 part, Mel 3-5 part.
3. the dermopathic herbal composite for the treatment of according to claim 1, it is characterized in that, the dermopathic herbal composite of described treatment comprises the raw material of following parts by weight: Radix Et Rhizoma Rhei 5 parts, Radix Scutellariae 7 parts, Cortex Phellodendri 8 parts, Cortex Dictamni 15 parts, Rhizoma Smilacis Glabrae 10 parts, Bombyx Batryticatus 3 parts, Radix Arnebiae (Radix Lithospermi) 8 parts, Fructus Arctii 11 parts, Flos Chrysanthemi Indici 4 parts, the Fructus Kochiae 12 parts, Radix Saposhnikoviae 6 parts.
4. the dermopathic herbal composite for the treatment of according to claim 2, is characterized in that, the dermopathic herbal composite of described treatment also comprises the raw material of following parts by weight: Flos Lonicerae 8 parts, Herba Lobeliae Chinensis 5 parts, Mel 5 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510264720.3A CN104800700B (en) | 2015-05-22 | 2015-05-22 | It is a kind of to treat dermopathic herbal composite |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510264720.3A CN104800700B (en) | 2015-05-22 | 2015-05-22 | It is a kind of to treat dermopathic herbal composite |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104800700A true CN104800700A (en) | 2015-07-29 |
| CN104800700B CN104800700B (en) | 2018-10-30 |
Family
ID=53686179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510264720.3A Expired - Fee Related CN104800700B (en) | 2015-05-22 | 2015-05-22 | It is a kind of to treat dermopathic herbal composite |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104800700B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105617156A (en) * | 2015-12-03 | 2016-06-01 | 杜军强 | Traditional Chinese medicinal preparation for treating various skin diseases |
| CN105998957A (en) * | 2016-07-11 | 2016-10-12 | 佛山杰致信息科技有限公司 | Externally applied traditional Chinese medicine composition |
| CN106138524A (en) * | 2016-08-30 | 2016-11-23 | 信阳师范学院 | One is used for treating dermopathic compositions and preparation method thereof |
| CN106491772A (en) * | 2016-02-03 | 2017-03-15 | 中卫清华园生物科技有限公司 | One kind treats psoriasic external use health medicine |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060099576A (en) * | 2005-03-14 | 2006-09-20 | 윤용지 | How to making atory dermatitis treatment function pack |
| CN102861272A (en) * | 2012-08-23 | 2013-01-09 | 景颖 | Preparation method of traditional Chinese medicine wet issue for treating urticaria papulosa |
-
2015
- 2015-05-22 CN CN201510264720.3A patent/CN104800700B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060099576A (en) * | 2005-03-14 | 2006-09-20 | 윤용지 | How to making atory dermatitis treatment function pack |
| CN102861272A (en) * | 2012-08-23 | 2013-01-09 | 景颖 | Preparation method of traditional Chinese medicine wet issue for treating urticaria papulosa |
Non-Patent Citations (1)
| Title |
|---|
| 黄慧芹等: "《常见皮肤病中医疗法》", 31 August 2010 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105617156A (en) * | 2015-12-03 | 2016-06-01 | 杜军强 | Traditional Chinese medicinal preparation for treating various skin diseases |
| CN106491772A (en) * | 2016-02-03 | 2017-03-15 | 中卫清华园生物科技有限公司 | One kind treats psoriasic external use health medicine |
| CN105998957A (en) * | 2016-07-11 | 2016-10-12 | 佛山杰致信息科技有限公司 | Externally applied traditional Chinese medicine composition |
| CN106138524A (en) * | 2016-08-30 | 2016-11-23 | 信阳师范学院 | One is used for treating dermopathic compositions and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104800700B (en) | 2018-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106421663A (en) | Medicine composition for treating rheumatoid bone disease and preparation method thereof | |
| CN104800700A (en) | Chinese herbal medicine composition for treating skin diseases | |
| CN101024026A (en) | Medicine for treating parotitis | |
| CN101716276B (en) | Preparation method of traditional Chinese medicine capsule for treating psoriasis | |
| CN102631454A (en) | Externally used traditional Chinese medicine for curing fracture postoperation synarthrophysis | |
| CN104873766A (en) | Medicine composition for treating rhinitis and preparation method thereof | |
| CN101480445A (en) | Medicine for treating dermatitis | |
| CN104337989A (en) | Traditional Chinese medicine composition containing centipeda minima and frankincense for treating gout | |
| CN103127465B (en) | Chinese medicament for treating mammary gland hyperplasia | |
| CN112972557A (en) | Medicinal liquor for treating arthralgia and myalgia and preparation method thereof | |
| CN1814218A (en) | Hormone external-dressing agent for treating dermatitis | |
| CN1297309C (en) | External medicine composition for curing arthralgia-syndrome of joint and preparation process thereof | |
| CN103656298A (en) | Traditional Chinese medicine preparation for curing hemicrania as well as preparation method and application thereof | |
| CN110279823B (en) | Traditional Chinese medicine composition for treating dengue fever and preparation method thereof | |
| CN101940677A (en) | Traditional Chinese medicinal powder for treating uarthritis | |
| CN106038905A (en) | Narcotic analgesic and preparation method thereof | |
| CN106074992A (en) | A kind of medical herbs for oral administration treating chest traumatic injury wound and using method thereof | |
| CN1167437C (en) | Prescription of medicine for curing heloma and planter wart | |
| CN103610743B (en) | One treats phthisical external Chinese medicinal liquid | |
| CN104147474A (en) | Externally-used ointment for treating tinea manus and tinea pedis | |
| CN104826043A (en) | Chinese medicinal formula for treating crural sprain | |
| CN1444952A (en) | Wiping and spreading tincture with wide effect and its preparing method | |
| CN104623278A (en) | External traditional Chinese medicine for treating heat toxin type acne | |
| CN103977313A (en) | Diuresis promoting and itching relieving pills and preparation method thereof | |
| CN116327741A (en) | Traditional Chinese medicine harmonizing cold compress patch |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181030 |